Jiangsu Yahong Meditech CoSHSE:688176 +13.75%48 Days Payable is 262.63 as of Mar. 2026, which is 96% below its 10-year median of 7,425.69. GuruFocus rates SHSE:688176 with a GF Score™ of 48/100 and a GF Value™ of ¥18.59 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 927 Drug Manufacturers companies, Jiangsu Yahong Meditech Co ranks better than 84.47% on this metric.
The historical rank and industry rank for Jiangsu Yahong Meditech Co's Days Payable or its related term are showing as below:
SHSE:688176'
s Days Payable Range Over the Past 10 Years
Min: 200.99 Med: 7425.69 Max: 14393592.5
Current: 200.99
During the past 8 years, Jiangsu Yahong Meditech Co's highest Days Payable was 14393592.50. The lowest was 200.99. And the median was 7425.69.
SHSE:688176's Days Payable is ranked better than 84.47% of 927
companies
in the Drug Manufacturers industry
Industry Median: 90.38
vs SHSE:688176: 200.99
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Yahong Meditech Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Yahong Meditech Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Yahong Meditech Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Jiangsu Yahong Meditech Co's Days Payable falls into.
Jiangsu Yahong Meditech Co Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Yahong Meditech Co (SHSE:688176) has a Days Payable of 262.63 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jiangsu Yahong Meditech Co and its competitors. This is 96% below median its historical median of 7,425.69. Over the past decade, Jiangsu Yahong Meditech Co's Days Payable has ranged from 200.99 to 14,393,592.50. According to the industry distribution chart, Jiangsu Yahong Meditech Co ranks #144 out of 927 companies in the Drug Manufacturers industry, placing it in the top 15.5%.
Is Jiangsu Yahong Meditech Co's Days Payable too high?
Jiangsu Yahong Meditech Co's current Days Payable of 262.63 is 96% below median its 10-year median of 7,425.69. Over the past 10 years, this metric has ranged from a low of 200.99 to a high of 14,393,592.50. The Drug Manufacturers industry median Days Payable is 90.38. Jiangsu Yahong Meditech Co's value of 262.63 is 190.6% above this industry median. Based on the distribution chart, Jiangsu Yahong Meditech Co ranks #144 out of 927 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Jiangsu Yahong Meditech Co has a GF Score™ of 48/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Yahong Meditech Co's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Jiangsu Yahong Meditech Co ranks #144 out of 927 companies for Days Payable. This places Jiangsu Yahong Meditech Co in the top 16% of its industry — outperforming the majority of peers. The industry median Days Payable is 90.38. Jiangsu Yahong Meditech Co's value of 262.63 is 190.6% above this benchmark. Historically, Jiangsu Yahong Meditech Co's own Days Payable has ranged from 200.99 to 14,393,592.50 over the past decade. While the company's 10-year median is 7,425.69 vs. the industry median of 90.38, Jiangsu Yahong Meditech Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.38, based on 927 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Yahong Meditech Co's current Days Payable of 262.63 is 190.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Jiangsu Yahong Meditech Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Yahong Meditech Co's current Days Payable is 262.63, which is 96% below median its own 10-year median of 7,425.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Yahong Meditech Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co (SHSE:688176) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥18.59, compared to a current price of ¥14.56 — trading 21.7% below its estimated fair value. The current Days Payable is 262.63, which is 96% below median its 10-year median of 7,425.69 and 190.6% above the Drug Manufacturers industry median of 90.38. Jiangsu Yahong Meditech Co's overall GF Score™ is 48/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Jiangsu Yahong Meditech Co (SHSE:688176), the current Days Payable is 262.63 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Yahong Meditech Co (SHSE:688176) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Yahong Meditech Co stock appears to be undervalued.
The current stock price of ¥14.56 is trading 21.7% below its estimated GF Value™ of ¥18.59.
GuruFocus considers Jiangsu Yahong Meditech Co to be Modestly Undervalued.
Key valuation signals for SHSE:688176:
Days Payable: 262.63 (96% below median its 10-year median of 7,425.69)
GF Value™: ¥18.59 vs. price of ¥14.56 (21.7% below fair value)
Industry Position: 190.6% above the Drug Manufacturers median (#144 of 927)
No single metric tells the full story. See the SHSE:688176 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commercialization in the field of focused treatment, providing the integration of diagnosis and treatment for Chinese and global patients Solutions.
48GF Score
Get the complete analysis for SHSE:688176
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688176 has been successfully added to your 
